Erectile dysfunction. Is an oral medication during the diagnostic pathway indicated?

Citation
H. Sperling et al., Erectile dysfunction. Is an oral medication during the diagnostic pathway indicated?, UROLOGE, 38(1), 1999, pp. 56-59
Citations number
14
Categorie Soggetti
Urology & Nephrology
Journal title
UROLOGE-AUSGABE A
ISSN journal
03402592 → ACNP
Volume
38
Issue
1
Year of publication
1999
Pages
56 - 59
Database
ISI
SICI code
0340-2592(199901)38:1<56:EDIAOM>2.0.ZU;2-L
Abstract
For patients with erectile dysfunction oral medication seems to be the most comfortable form of application. This can also be seen in the expectations looking forward to Sildenafil and other drugs in development. We present a prospective examination with the oral medication of 100 mg acecarbamol, 30 mg extract of cortex quebracho and 33 mg tocopherol acetate (Afrodor(R)) i n 100 patients complaining secondary erectile dysfunction. The patients wer e treated unselected with 3 x 1 tablet/day during the diagnostic schedule. 14 % of the patients were able to perform satisfying sexual intercourse aft er 4 weeks of medication and another 15 % showed an increased libido. There fore we suggest, that the application of an oral medication, might be usefu l, especially during the time of diagnostics. Especially for those patients who gain without invasive diagnostic roofs as intracavernous injection.